Plaque Modification Devices

Plaque Modification Devices Market Outlook

The global plaque modification devices market is projected to reach a valuation of approximately USD 5.1 billion by 2035, growing at a CAGR of around 7.2% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, which necessitate innovative medical interventions to manage plaque buildup effectively. Additionally, advancements in medical technology, increasing healthcare expenditures, and rising awareness regarding preventive healthcare are expected to further propel market growth. Furthermore, an aging global population, coupled with lifestyle changes contributing to the rise in obesity and diabetes, underlines the critical need for effective plaque modification devices. Collectively, these factors are creating a robust market environment ripe for expansion and innovation in plaque modification technologies.

Growth Factor of the Market

The plaque modification devices market is experiencing significant growth due to a variety of factors contributing to its expansion. Firstly, the rise in the geriatric population is leading to an increase in the incidence of chronic diseases such as coronary artery disease and peripheral artery disease, prompting the need for advanced plaque modification devices. Moreover, technological advancements in minimally invasive procedures are enhancing the efficacy and safety of these devices, making them more appealing to both healthcare providers and patients. The growing number of interventional cardiology procedures performed globally is another critical growth factor, with an increasing acceptance of procedures such as angioplasty and stenting. Additionally, favorable reimbursement policies in many regions are encouraging healthcare facilities to adopt advanced plaque modification solutions, subsequently boosting market demand. Lastly, increased investment in research and development for innovative devices is expected to result in new product launches, further driving market growth.

Key Highlights of the Market

• Projected market growth at a CAGR of 7.2% from 2025 to 2035.
• Technological advancements in minimally invasive procedures are enhancing device efficacy.
• Rising prevalence of cardiovascular diseases globally is driving demand.
• Growing geriatric population is increasing the need for effective treatment options.
• Favorable reimbursement policies are encouraging the adoption of advanced devices.

By Product Type

Atherectomy Devices:

Atherectomy devices are specialized instruments designed to remove atherosclerotic plaque from the walls of arteries, primarily in patients with coronary artery disease. These devices utilize various mechanisms, including rotational and directional approaches, to excise or ablate plaque, thereby restoring normal blood flow. The growing prevalence of coronary artery diseases and the increasing number of atherectomy procedures are propelling the demand for these devices. Furthermore, innovations in atherectomy techniques, enhancing safety and efficacy, are likely to broaden their application and acceptance in clinical practice. The integration of advanced imaging technologies with atherectomy devices is expected to further improve their performance, providing real-time visualization during procedures and ensuring optimal outcomes for patients.

Thrombectomy Devices:

Thrombectomy devices are critical tools used to remove blood clots that obstruct blood vessels, aiming to restore normal blood flow quickly and efficiently. The rising incidence of thrombotic events, particularly in patients with cardiovascular diseases, has heightened the demand for these devices. Thrombectomy procedures, which can be performed using either mechanical or aspiration techniques, have gained traction due to their effectiveness in minimizing complications associated with clotting. The continuous innovation in thrombectomy technologies, such as the development of more efficient retrieval systems, is expected to enhance patient outcomes and minimize procedural risks. As healthcare providers focus on improving patient care and reducing hospital stays, the need for thrombectomy devices is anticipated to grow significantly, driving market expansion.

Laser Ablation Devices:

Laser ablation devices employ focused laser energy to vaporize or coagulate tissue, making them particularly effective in treating vascular lesions and atherosclerotic plaques. These devices minimize damage to surrounding tissues, which is a significant advantage over traditional surgical methods. The growing preference for minimally invasive procedures is driving the adoption of laser ablation devices, particularly in interventional cardiology and peripheral vascular interventions. With advancements in laser technology, newer devices are becoming available that offer increased precision and versatility, catering to a wider range of clinical applications. Furthermore, the ability to achieve rapid recovery times and reduced patient discomfort associated with laser procedures is expected to fuel market growth in this segment.

Angioplasty Balloons:

Angioplasty balloons play a vital role in the treatment of narrowed or blocked arteries, particularly in patients with coronary artery disease. These devices are inflated to widen the artery and restore blood flow, often paired with stenting for optimal results. The increasing prevalence of cardiovascular diseases is significantly propelling the demand for angioplasty procedures and, consequently, angioplasty balloons. Technological advancements, such as the development of drug-coated balloons, which release therapeutic agents to reduce the risk of restenosis, are enhancing the efficacy of these devices. As healthcare providers continue to focus on improving patient outcomes and minimizing procedural risks, the demand for innovative angioplasty balloon technologies is expected to rise, further driving market growth.

Stents:

Stents are small, mesh-like devices implanted in narrowed arteries to keep them open and ensure unobstructed blood flow. Their widespread use in treating coronary artery disease has made them a cornerstone of interventional cardiology. The increasing incidence of heart-related ailments and the growing number of percutaneous coronary interventions (PCIs) are significant factors contributing to the robust demand for stents. Recent advancements in stent technology, including the development of bioresorbable stents and drug-eluting stents, have enhanced their efficacy and safety profiles. These innovations are expected to reduce complications such as thrombus formation and restenosis, driving further adoption. As patient preferences shift towards less invasive treatment alternatives, the stents segment is poised for substantial growth in the years to come.

By Application

Coronary Artery Disease:

Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality worldwide, characterized by the buildup of plaque in the coronary arteries, leading to reduced blood flow to the heart. The rising prevalence of CAD is significantly driving the demand for plaque modification devices, as healthcare providers strive to deliver effective interventions to manage this condition. The increasing adoption of minimally invasive procedures, combined with advancements in device technologies, is enhancing treatment outcomes for CAD patients. Moreover, the emphasis on early diagnosis and timely intervention is further amplifying market demand. As healthcare systems evolve to address the growing burden of CAD, a robust market for plaque modification devices specifically targeting this application is expected to flourish.

Peripheral Artery Disease:

Peripheral artery disease (PAD) affects millions of individuals globally, leading to the narrowing of peripheral arteries, primarily in the legs. This condition often results in pain and limited mobility, significantly impacting patients' quality of life. The rising awareness of PAD and the need for effective treatment options are contributing to the robust growth of plaque modification devices focused on this application. The increasing number of revascularization procedures aimed at treating PAD is further propelling market demand. Additionally, the development of innovative devices tailored for treating complex lesions in peripheral arteries is expected to enhance clinical outcomes and expand treatment options for healthcare providers. As the prevalence of PAD continues to rise, the market for plaque modification devices aimed at this critical application is anticipated to grow substantially.

Neurovascular Disease:

Neurovascular diseases, including conditions like stroke and transient ischemic attacks, represent a significant public health challenge due to their high morbidity and mortality rates. The increasing incidence of these diseases is driving the demand for plaque modification devices that can effectively address vascular blockages in the brain. Technologies such as thrombectomy devices and laser ablation devices are particularly relevant in the management of neurovascular conditions. The growing utilization of advanced imaging techniques to diagnose and treat neurovascular diseases is further enhancing the efficacy and safety of interventions. As healthcare providers increasingly focus on minimizing the long-term impact of neurovascular diseases, the market for plaque modification devices tailored for this application is projected to experience robust growth.

By User

Hospitals:

Hospitals remain the primary end-users of plaque modification devices due to their capacity to provide comprehensive care, including advanced diagnostic and therapeutic interventions. The rising prevalence of cardiovascular and neurovascular diseases is driving the demand for these devices in hospital settings, as clinicians strive to deliver effective treatments to manage these conditions. Furthermore, hospitals are increasingly adopting minimally invasive surgical techniques, which are facilitated by advanced plaque modification devices, leading to improved patient outcomes and shorter recovery times. Additionally, the establishment of specialized cardiac and vascular centers within hospitals is expected to further enhance the utilization of plaque modification devices. As the healthcare landscape continues to evolve, the hospital segment is anticipated to witness significant growth in the adoption of these innovative devices.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly becoming important players in the plaque modification devices market due to their capacity to offer outpatient care for various procedures. The rising preference for minimally invasive procedures, which can often be performed in ASCs, is driving the adoption of plaque modification devices in this setting. Patients benefit from shorter recovery times and reduced hospital stays, making ASCs an attractive option for both providers and patients. The growing demand for interventional procedures, such as angioplasty and stenting, is further propelling the market for plaque modification devices within ASCs. Additionally, advancements in technology are facilitating the development of specialized devices that cater specifically to outpatient settings, enhancing their efficacy and safety profiles. As the trend towards outpatient care continues, the ASC segment is poised for significant growth in the coming years.

Specialty Clinics:

Specialty clinics are emerging as vital players in the plaque modification devices market, offering targeted care for patients with cardiovascular and neurovascular diseases. These clinics often focus on specific conditions, providing tailored care and interventions that enhance patient outcomes. The increasing prevalence of chronic diseases is driving demand for specialized services, as patients seek expert care and advanced treatment options for their conditions. Furthermore, the emphasis on patient-centered care and personalized treatment plans is fueling the growth of specialty clinics, encouraging the adoption of innovative plaque modification devices. With advancements in technology and a growing awareness of the importance of early intervention, specialty clinics are expected to play a significant role in the marketplace, further broadening access to essential plaque modification therapies.

By Technology

Rotational Atherectomy:

Rotational atherectomy is a specialized technique utilized for the removal of atherosclerotic plaque from the arterial walls through the use of a rotating diamond-coated burr. This technology is particularly effective in treating calcified lesions that are often challenging to manage with standard balloon angioplasty alone. The demand for rotational atherectomy devices is growing as more physicians recognize their efficacy in enhancing procedural outcomes and reducing the risk of complications associated with plaque burden. The increasing prevalence of complex coronary artery disease cases is further driving the adoption of this technology. With continued advancements in device design and performance, rotational atherectomy is expected to play a pivotal role in the plaque modification devices market.

Directional Atherectomy:

Directional atherectomy is another crucial technology employed in plaque modification, allowing for the selective removal of atherosclerotic plaque from specific areas of the artery. This approach enables physicians to achieve optimal results while preserving the surrounding healthy tissue. The growing recognition of the benefits of directional atherectomy in terms of improved patient outcomes and reduced complications is driving its adoption among healthcare providers. As the prevalence of peripheral artery disease and coronary artery disease continues to rise, the demand for directional atherectomy devices is expected to increase. Furthermore, ongoing technological advancements aimed at enhancing the precision and effectiveness of these devices will likely contribute to their market growth.

Laser Ablation:

Laser ablation technology utilizes light energy to vaporize or coagulate atherosclerotic plaque, offering a minimally invasive alternative to traditional surgical approaches. The growing preference for less invasive procedures, combined with the advantages of laser ablation in terms of precision and reduced recovery time, is driving the demand for these devices. The increasing incidence of vascular diseases necessitates effective treatment options, making laser ablation a valuable tool in the clinician's arsenal. As research progresses and new laser technologies are developed, the scope of applications for laser ablation devices is expected to expand, further solidifying their position in the plaque modification devices market.

Drug-Coated Balloons:

Drug-coated balloons represent a significant advancement in the treatment of atherosclerotic lesions, as they combine the mechanical dilation of standard balloons with the localized delivery of therapeutic agents to reduce restenosis rates. This innovation is particularly beneficial for patients with a high risk of re-narrowing of the artery following conventional interventions. The increasing acceptance of drug-coated balloons among healthcare providers and patients alike is driving their adoption across various vascular procedures. Their efficacy in maintaining vessel patency, combined with the trend towards minimally invasive procedures, is expected to propel the growth of this segment within the plaque modification devices market. As ongoing research leads to the development of new drug formulations and technologies, the potential applications for drug-coated balloons are projected to expand further.

By Region

The North American plaque modification devices market is the largest globally, driven by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and increased investment in innovative medical technologies. The region is expected to witness a CAGR of approximately 6.9% during the forecast period, fueled by the growing adoption of minimally invasive procedures and favorable reimbursement policies. Additionally, the presence of key market players and continuous advancements in device technologies significantly contribute to North America's dominant position in the plaque modification devices market. As healthcare providers focus on improving patient outcomes and reducing complications associated with vascular diseases, the demand for advanced plaque modification devices in this region is anticipated to increase steadily.

In Europe, the plaque modification devices market is also experiencing significant growth, driven by an aging population, rising healthcare expenditures, and the increasing prevalence of chronic diseases. The European market is expected to grow at a CAGR of around 7.1% from 2025 to 2035, as healthcare systems continue to adopt advanced technologies and procedures to manage cardiovascular and neurovascular conditions. The growing emphasis on patient-centered care and personalized medicine is propelling the demand for innovative plaque modification devices across the region. Furthermore, ongoing collaborations between healthcare providers, research institutions, and device manufacturers are facilitating the development of new technologies, further boosting the European market's growth potential. The combined factors of increased disease prevalence, technological advancements, and shifting healthcare paradigms are expected to substantiate the expansion of plaque modification devices in Europe.

Opportunities

The plaque modification devices market is ripe with opportunities, particularly as healthcare systems worldwide prioritize preventative care and early intervention strategies. This shift is being driven by the rising prevalence of lifestyle-related diseases such as obesity, diabetes, and hypertension, which are significant risk factors for cardiovascular and neurovascular diseases. By focusing on early diagnosis and timely treatment, healthcare providers can minimize the long-term impact of these conditions on patients' health. Consequently, there is a growing demand for advanced plaque modification devices that can effectively address the needs of this patient population. Manufacturers and technology developers can capitalize on this trend by innovating and introducing new products designed to meet the specific requirements of modern healthcare environments, ultimately expanding their market share in this burgeoning sector.

Additionally, the increasing investments in healthcare technology, particularly in emerging markets, offer significant growth potential for plaque modification devices. As countries like India, Brazil, and China continue to develop their healthcare infrastructures, the demand for advanced medical equipment and technologies is on the rise. Stakeholders in the market can take advantage of this opportunity by expanding their presence in these regions and establishing partnerships with local healthcare providers. Furthermore, the increasing emphasis on research and development within the medical device industry is expected to yield innovative solutions that enhance treatment outcomes and patient experiences. By leveraging these opportunities, companies can position themselves as leaders in the plaque modification devices market, driving both growth and improved health outcomes for patients globally.

Threats

Despite the promising growth trajectory of the plaque modification devices market, several threats could impede its expansion. One significant challenge is the increasing regulatory scrutiny surrounding medical devices, which requires manufacturers to navigate complex approval processes and comply with stringent quality standards. This can lead to delays in bringing new products to market and may deter innovation within the industry. Additionally, the presence of well-established competitors can create intense rivalry, driving prices down and potentially squeezing profit margins for companies operating within the plaque modification devices sector. As healthcare providers seek cost-effective solutions, the need for continuous innovation and differentiation becomes paramount for companies looking to maintain a competitive edge.

Moreover, the availability of alternative treatment options, such as pharmacotherapy and lifestyle modifications, may pose a challenge to the adoption of plaque modification devices. As medical professionals emphasize comprehensive approaches to managing cardiovascular and neurovascular diseases, patients may opt for non-invasive methods over device-assisted interventions. This could adversely affect market growth, especially in regions where access to advanced medical technologies is limited. To mitigate these threats, stakeholders in the plaque modification devices market must invest in research and development, focus on product differentiation, and engage in strategic marketing efforts to raise awareness about the benefits of their devices.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Edwards Lifesciences Corporation
• Cardinal Health, Inc.
• Terumo Corporation
• Johnson & Johnson
• Cook Medical
• Spectranetics Corporation
• AngioDynamics, Inc.
• Cardiovascular Systems, Inc.
• B. Braun Melsungen AG
• Asahi Intecc Co., Ltd.
• Conmed Corporation
• Siemens Healthineers

The competitive landscape of the plaque modification devices market is characterized by the presence of several key players, each vying for market share through innovation, strategic partnerships, and aggressive marketing strategies. Companies such as Medtronic and Boston Scientific are at the forefront of the market, leveraging their extensive product portfolios, robust distribution networks, and strong brand recognition to capture a significant share of the market. These industry giants are continuously investing in research and development to create advanced devices that meet the evolving needs of healthcare providers and patients alike. Furthermore, collaborations with healthcare institutions for clinical trials and product evaluations are enhancing their product offerings and expanding their market reach.

Abbott Laboratories and Edwards Lifesciences also play crucial roles in the plaque modification devices market, focusing on technological advancements and offering specialized products designed to improve patient outcomes. Their commitment to innovation is reflected in their ongoing investments in research and development, leading to the introduction of cutting-edge devices that cater to specific clinical needs. Additionally, their strong global presence enables them to effectively reach diverse patient populations, thereby maximizing their market potential. As competition intensifies, these companies are likely to pursue mergers and acquisitions to strengthen their positions and accelerate market growth.

Emerging companies and smaller players, such as Cardiovascular Systems and AngioDynamics, are also making strides in the plaque modification devices market by focusing on niche segments and developing specialized products that address unmet clinical needs. Their agility in responding to market trends and their emphasis on customer-centric solutions are allowing them to carve out unique positions in the marketplace. As the demand for minimally invasive procedures continues to rise, these players are well-positioned to capture market share by providing innovative solutions tailored to specific patient populations, ultimately contributing to the overall growth of the plaque modification devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Johnson & Johnson
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Conmed Corporation
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Terumo Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 AngioDynamics, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Siemens Healthineers
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 B. Braun Melsungen AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Asahi Intecc Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Spectranetics Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cardiovascular Systems, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Edwards Lifesciences Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Plaque Modification Devices Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
  • 6.2 Plaque Modification Devices Market, By Technology
    • 6.2.1 Rotational Atherectomy
    • 6.2.2 Directional Atherectomy
    • 6.2.3 Laser Ablation
    • 6.2.4 Drug-Coated Balloons
  • 6.3 Plaque Modification Devices Market, By Application
    • 6.3.1 Coronary Artery Disease
    • 6.3.2 Peripheral Artery Disease
    • 6.3.3 Neurovascular Disease
  • 6.4 Plaque Modification Devices Market, By Product Type
    • 6.4.1 Atherectomy Devices
    • 6.4.2 Thrombectomy Devices
    • 6.4.3 Laser Ablation Devices
    • 6.4.4 Angioplasty Balloons
    • 6.4.5 Stents

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Plaque Modification Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Plaque Modification Devices market is categorized based on

By Product Type

• Atherectomy Devices
• Thrombectomy Devices
• Laser Ablation Devices
• Angioplasty Balloons
• Stents

By Application

• Coronary Artery Disease
• Peripheral Artery Disease
• Neurovascular Disease

By User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Technology

• Rotational Atherectomy
• Directional Atherectomy
• Laser Ablation
• Drug-Coated Balloons

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Edwards Lifesciences Corporation
• Cardinal Health, Inc.
• Terumo Corporation
• Johnson & Johnson
• Cook Medical
• Spectranetics Corporation
• AngioDynamics, Inc.
• Cardiovascular Systems, Inc.
• B. Braun Melsungen AG
• Asahi Intecc Co., Ltd.
• Conmed Corporation
• Siemens Healthineers